A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine

Exclusion Criteria

• •Clinically significant medical condition
• •Clinically significant history of ECG abnormalities or family history of QTc interval syndrome
• •Use of tobacco and/or nicotine products \>3 months prior to screening
• •Use of any prescription medications within 14 days prior to screening
• •Use of over the counter medications (including herbal products) within 7 days prior to screening